HomeADPT • NASDAQ
add
Adaptive Biotechnologies Corp
Previous close
$19.66
Day range
$18.82 - $19.31
Year range
$5.81 - $20.74
Market cap
2.90B USD
Avg Volume
2.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 93.97M | 102.38% |
Operating expense | 65.53M | 5.01% |
Net income | 9.55M | 129.77% |
Net profit margin | 10.16 | 114.71% |
Earnings per share | 0.06 | 127.76% |
EBITDA | 14.70M | 152.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 212.77M | -12.56% |
Total assets | 490.61M | -12.16% |
Total liabilities | 286.36M | -14.50% |
Total equity | 204.25M | — |
Shares outstanding | 152.67M | — |
Price to book | 14.67 | — |
Return on assets | 5.21% | — |
Return on capital | 6.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 9.55M | 129.77% |
Cash from operations | -7.13M | 73.67% |
Cash from investing | 17.28M | 226.90% |
Cash from financing | 1.68M | 4,110.00% |
Net change in cash | 11.84M | 154.47% |
Free cash flow | 9.52M | 190.49% |
About
CEO
Founded
2009
Headquarters
Website
Employees
619
